Ophthalmic nerve hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy
Citation Manager Formats
Make Comment
See Comments

A 59-year-old woman with a long-standing diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) developed facial numbness and exophthalmos. Sural nerve biopsy revealed onion bulb formation consistent with CIDP. Neurologic examinations revealed distal dominant muscle atrophy with areflexia and impairment of all sensory modalities; cranial nerve involvement, including bilateral exophthalmos, left-side facial palsy, and left-side periorbital hypoesthesia; and swelling of the sural and subclavian nerves. MRI demonstrated marked thickening of bilateral ophthalmic nerves (figure). Such a finding has been reported rarely in the literature.1 Neurologists should be aware that patients with CIDP might show exophthalmos due to ophthalmic nerve hypertrophy.
Our patient exhibited bilateral exophthalmos (A, B). Cranial T2-weighted MRI (C) and 3D magnetic resonance cisternography (D) depict abnormal swelling of bilateral supraorbital and supratrochlear nerves, which are branches of ophthalmic nerves in the orbit. Cervical T2-weighted MRI depicts hypertrophic nerve roots (E).
Footnotes
Author contributions: Ayami Okuzumi: drafted the manuscript, acquired the data, accepts responsibility for conduct of research, and final approval. Taku Hatano: drafted and revised the manuscript, planned the study concept and design, acquired the data, analyzed and interpreted the data, accepts responsibility for conduct of research, and final approval. Toshiki Nakahara: participated in the data collection. Kazumasa Yokoyama: participated in the data collection and revised the content of the manuscript. Nobutaka Hattori: revised the content of the manuscript.
Study funding: Supported by Strategic Research Foundation Grant-in-Aid Project for Private Universities, Grants-in-Aid for Scientific Research (KAKENHI) (to T.H., 25461290), from the Japanese Ministry of Education, Culture, Sports, Science and Technology.
Disclosure: A. Okuzumi and T. Nakahara report no disclosures. T. Hatano received research support from Strategic Research Foundation Grant-in-Aid Project for Private Universities, Grants-in-Aid for Scientific Research (KAKENHI 25461290 PI). K. Yokoyama received honoraria for oral speaker from Bayer Healthcare Global advisory board. He served as advisory board member of MS Frontier, medical review company, Tokyo, Japan. N. Hattori served on the editorial boards of Movement Disorders, the Journal of Neurology, Neurosurgery & Psychiatry, and the Journal of Neural Transmission. Go to Neurology.org for full disclosures.
- © 2014 American Academy of Neurology
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.